arrow
R

Ragunath Singaravelu

University of Ottawa
H指数:25
被引数:1,740

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses

抗生素介导的随机诱变和表达细胞因子的溶瘤病毒的选择

2024-11-281
PRE
Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development
2023-06-010
OAAI
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies
2023-05-2618
OAAI
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX
2023-01-136
OAAI
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen

在生物反应器药物筛选后鉴定FDA批准的联苯苄唑作为SARS-CoV-2阻断剂

2022-09-016
OAAI
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection
2022-05-0119
OAAI
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy

病毒程序化的细胞外囊泡使癌细胞对溶瘤病毒和小分子疗法敏感

2022-04-0730
OAAI
Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern
2021-10-1820
PRE
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry
2021-06-0122
OAAI
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization

SARS-CoV-2疫苗设计的意义: 刺突糖蛋白跨膜结构域与受体结合结构域的融合诱导三聚化

2020-08-3020
OAAI